1. 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. Issue 14 (September 2015) Authors: Picozzi, Vincent J.; Ramanathan, Ramesh K.; Lowery, Maeve A.; Ocean, Allyson J.; Mitchel, Edith P.; O'Neil, Bert H.; Guarino, Michael J.; Conkling, Paul R.; Cohen, Steven J.; Bahary, Nathan; Frank, Richard C.; Dragovich, Tomislav; Bridges, Benjamin B.; Braiteh, Fadi S.; Starodub, Alexander N.; Le... Journal: European journal of cancer Issue: Volume 51:Issue 14(2015:Sep.) Page Start: 1857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. Issue 14 (September 2015) Authors: Picozzi, Vincent J.; Ramanathan, Ramesh K.; Lowery, Maeve A.; Ocean, Allyson J.; Mitchel, Edith P.; O'Neil, Bert H.; Guarino, Michael J.; Conkling, Paul R.; Cohen, Steven J.; Bahary, Nathan; Frank, Richard C.; Dragovich, Tomislav; Bridges, Benjamin B.; Braiteh, Fadi S.; Starodub, Alexander N.; Le... Journal: European journal of cancer Issue: Volume 51:Issue 14(2015:Sep.) Page Start: 1857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CT-01 Phase IB study of IMMU-115 (humanised ANTI-CD74 antibody) targeting antigen presenting cells in patients with systemic lupus erythematosus (SLE). (31st August 2016) Authors: Wallace, Daniel J; Wegener, William A; Horne, Heather; Goldenberg, David M Journal: Lupus science & medicine Issue: Volume 3(2016)Supplement 1 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low‐dose anti‐CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study. (6th July 2013) Authors: Liebman, Howard A.; Saleh, Mansoor N.; Bussel, James B.; Negrea, Ovidiu George; Horne, Heather; Wegener, William A.; Goldenberg, David M. Journal: British journal of haematology Issue: Volume 162:Number 5(2013:Sep.) Page Start: 693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase I, multicentre, dose‐escalation trial of monotherapy with milatuzumab (humanized anti‐CD74 monoclonal antibody) in relapsed or refractory multiple myeloma. (25th September 2013) Authors: Kaufman, Jonathan L.; Niesvizky, Ruben; Stadtmauer, Edward A.; Chanan‐Khan, Asher; Siegel, David; Horne, Heather; Wegener, William A.; Goldenberg, David M. Journal: British journal of haematology Issue: Volume 163:Number 4(2013:Nov.) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia*. Issue 4 (2nd April 2016) Authors: Kalaycio, Matt E.; George Negrea, O.; Allen, Steven L.; Rai, Kanti R.; Abbasi, Rashid M.; Horne, Heather; Wegener, William A.; Goldenberg, David M. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 4(2016:Apr.) Page Start: 803 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗